Chronic liver diseases, such as viral hepatitis, alcoholic liver disease, or non-alcoholic fatty
liver disease, are characterized by continual inflammation, progressive destruction and …

Background & Aims Chronic hepatitis B (CHB) disproportionately impacts foreign-born
patients and those of Asian or Black race. Given the paucity of data, we aimed to study the …

Aim of the study: Chronic hepatitis B virus (HBV) infection is one of the major health
problems worldwide. Use of non-invasive tests for assessment of hepatic fibrosis such as the …

In sub-Saharan Africa (SSA), the (sub) genotypes A1, D3, and E of the hepatitis B virus
(HBV) prevail. Individuals infected with subgenotype A1 have a 4.5-fold increased risk of …

Introduction Oral nucleos (t) ide analogues (NUCs) are recommended as first-line therapy
for chronic hepatitis B (CHB) due to higher HBV-DNA suppression rates and safety profile …

Background: Patients with hepatocellular carcinoma (HCC) and with a single tumor< 2 cm in
size are classified as having Barcelona Clinic Liver Cancer (BCLC) stage 0 HCC. We aimed …

Abstract Introduction and Objectives In hepatocellular carcinoma (HCC), the prognosis of
patients with microvascular invasion (MVI) is poor. Therefore, in this study, we established …

Liver cancer is often deadly, but the chances of survival can be improved by early detection,
which opens the door for curative treatments, such as resection and liver transplantation …

Purpose We tested a recently developed short peptide radioligand for PET imaging of
hepatocellular carcinoma (HCC) by targeting an oncoprotein, extra-domain B fibronectin …

Simple Summary Molecular directed therapy for hepatocellular carcinoma (HCC) involves
targeting specific signaling pathways that normally promote cancer cell growth and survival …